glp-1 news A wave of new #GLP1 drug options for type 2 #Diabetes and #Obesity was a major focus at #ADA2026. In the latest JAMA Medical podcast, Jennifer Abbasi interviews Rita Kalyani, MD News Brief: FDA Seeks Removal

Clinical trial design for alcoholic hepatitis

A Washington State University investigation found that the lead author altered images in her dissertation and at least four co-authored papers from 2011-2014

Insurance coverage is very useful for making Zepbound affordable and accessible

The absence of a defined receptor target means that batch-to-batch consistency in peptide identity and purity is particularly important, because the usual pharmacodynamic markers that guide concentration selection for receptor-targeted peptides are not available for this research tool

For suspected trimethylaminuria urinary testing measuring TMA and TMAO in steady state or after a dietary challenge can be informative

Essential Supplies for a Successful Reconstitution Process Materials Needed Before you dive into the reconstitution process, youll need to gather specific materials